Oriola Oyj
LSE:0NES
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| FI |
O
|
Oriola Oyj
OMXH:OKDBV
|
195.6m EUR |
Loading...
|
|
| US |
|
Mckesson Corp
NYSE:MCK
|
116.2B USD |
Loading...
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
70.3B USD |
Loading...
|
|
| US |
|
Cencora Inc
NYSE:COR
|
69.8B USD |
Loading...
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
52.8B USD |
Loading...
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
34.3B AUD |
Loading...
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.6B CNY |
Loading...
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
63.1B CNY |
Loading...
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.3B USD |
Loading...
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
65.8B HKD |
Loading...
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW |
Loading...
|
Market Distribution
| Min | -441.9% |
| 30th Percentile | 28.8% |
| Median | 45.6% |
| 70th Percentile | 67.4% |
| Max | 21 276.1% |
Other Profitability Ratios
Oriola Oyj
Glance View
Oriola Corp. engages in the provision of pharmaceutical, and health and well-being products retail and wholesale. The company is headquartered in Espoo, Etela-Suomen and currently employs 2,645 full-time employees. The company went IPO on 2006-07-03. The firm is engaged in the retail and wholesale of pharmaceuticals, acting as a channel between pharmaceutical manufacturers and consumers, primarily in Finland and Sweden. The firm's reporting segments are Consumer, Services, and Healthcare. Through its own pharmacies, the Company provides consumers with not only medicines and pharmaceutical advice but also a selection of healthcare consumer products and customer service. The firm is active through a number of subsidiaries located throughout Europe, including PharmaService OY, Oriola AB, Oriola Oyj, Farenta Oy, Kronans Droghandel Apotek AB and Svensk dos AB.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Oriola Oyj is 9%, which is below its 3-year median of 10.2%.
Over the last 3 years, Oriola Oyj’s Gross Margin has decreased from 12.4% to 9%. During this period, it reached a low of 9% on Sep 30, 2025 and a high of 12.4% on Sep 30, 2022.
